Abstract

BackgroundInflammation-based prognostic scores have been used as outcome predictors in patients with cancer or on hemodialysis. However, their role in patients on continuous ambulatory peritoneal dialysis (CAPD) remains unclear. This study aimed to examine the prognostic value of inflammation-based composite scores for mortality in CAPD patients.MethodsThis study was conducted in CAPD patients enrolled from January 1, 2006 to December 31, 2014 and followed until December 31, 2016. Three inflammation-based prognostic scores, including Glasgow prognostic score (GPS), prognostic nutritional index (PNI), and prognostic index (PI), were conducted in this study. The associations between these scores and all-cause or cardiovascular mortality were evaluated by Kaplan–Meier method and Cox proportional hazards models. The areas under the curve (AUC) of receiver-operating characteristic (ROC) analysis were used to determine the predictive values of mortality.ResultsA total of 1501 patients were included. During a median follow-up of 38.7 (range, 21.6–62.3) months, 346 (23.1%) patients died, of which 168 (48.6%) were due to cardiovascular diseases (CVD). After adjustment for confounders, the results showed that elevated GPS, PNI, and PI scores were all independently associated with all-cause [GPS: Score 1: hazard ratio(HR) 3.94, 95% confidence interval(CI) 2.90–5.35; Score 2: HR 7.56, 95% CI 5.35–10.67; PNI: HR 1.82, 95% CI 1.36–2.43; PI: Score 1: HR 2.08, 95% CI 1.63–2.65; Score 2: HR 3.03, 95% CI 2.00–4.60)] and CVD mortality(GPS: Score 1: HR 4.41, 95% CI 2.76–7.03; Score 2: HR 9.64, 95% CI 5.72–16.26; PNI: HR 1.63, 95% CI 1.06–2.51; PI: Score 1: HR 2.57, 95% CI 1.81–3.66, Score 2: HR 3.85, 95% CI 1.99–7.46).The AUC values of GPS score were 0.798 (95% CI0.770–0.826) for all-cause mortality and 0.781 (95% CI 0.744–0.817) for CVD mortality, both of which significantly higher than those of PNI and PI scores (P < 0.001, respectively).ConclusionsAll elevated GPS, PNI, and PI scores were independently associated with all-cause and CVD mortality. The GPS score showed better predictive value than PNI and PI scores in CAPD patients.

Highlights

  • Inflammation-based prognostic scores have been used as outcome predictors in patients with cancer or on hemodialysis

  • International Society for Peritoneal Dialysis (ISPD) cardiovascular and metabolic guidelines suggest that Peritoneal dialysis (PD) patients with persistently elevated C-reactive protein (CRP) should be investigated for any treatable cause of inflammation and nutritional status should be assessed within 6–8 weeks after commencement of PD for reducing the risk of cardiovascular disease (CVD) mortality [2]

  • After adjusting for covariates including age, blood pressure (BP), diabetes, hypertension, cardiovascular disease, infection, hemoglobin, total triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), uric acid, and creatinine, the patients with increased Glasgow prognostic score (GPS) scores still had a significant increased risk for overall [prognostic nutritional index (PNI) prognostic nutritional index (Score) 1: hazard ratio(HR) 3.94, 95% confidence interval(CI) 2.90–5.35, P < 0.001; Score 2: HR 7.56, 95% Confidence interval (CI) 5.35– 10.67, P < 0.001] and CVD mortality (Score 1: HR 4.41, 95% CI 2.76–7.03,P < 0.001; Score 2: HR 9.64, 95% CI 5.72–16.26, P < 0.001)

Read more

Summary

Introduction

Inflammation-based prognostic scores have been used as outcome predictors in patients with cancer or on hemodialysis. Their role in patients on continuous ambulatory peritoneal dialysis (CAPD) remains unclear. The mortality of PD patients remains much higher compared to general population, nearly half of which are caused by cardiovascular disease (CVD) [2, 3]. International Society for Peritoneal Dialysis (ISPD) cardiovascular and metabolic guidelines suggest that PD patients with persistently elevated CRP should be investigated for any treatable cause of inflammation and nutritional status should be assessed within 6–8 weeks after commencement of PD for reducing the risk of CVD mortality [2]. Standardized methods or systems available for this purpose remain to be explored

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call